Adenomyosis, Fertility, and the Supportive Role of Progesterone

Living with adenomyosis can feel isolating. The pain that arrives with each cycle, the heavy bleeding, the worry about what it all means for your hopes of having a child. These are not small things. If you have been told you have adenomyosis, or if you suspect it, please know that you are far from alone. Research suggests that roughly one in ten women experiencing subfertility has adenomyosis as a contributing factor, and many more live with the condition for years before receiving a clear diagnosis.

What makes adenomyosis particularly difficult is not just the symptoms themselves but the lack of clear answers around how to manage them. Unlike many other gynecological conditions, adenomyosis does not have a set of standardized treatment guidelines. There is no universally agreed upon protocol that physicians follow, which means care is often pieced together based on individual experience, expert opinion, and what works for each patient. For women already navigating the emotional weight of infertility, this uncertainty can feel like one more obstacle in an already long road.

What Adenomyosis Actually Is

Adenomyosis is a chronic uterine condition in which tissue similar to the lining of the uterus grows within the muscular wall of the uterus itself. The result is an inflamed, often enlarged uterus that responds painfully to the normal hormonal rhythms of each cycle. Symptoms commonly include painful periods, heavy or irregular bleeding, chronic pelvic pain, and discomfort during intimacy. For many women, the impact reaches well beyond the physical. Daily activities, work, relationships, and emotional wellbeing can all be affected by a condition that is often invisible to everyone but the person living with it.

For women trying to conceive, the picture becomes even more complex. Adenomyosis can interfere with implantation, alter the uterine environment, and contribute to subfertility. The desire to preserve fertility while also finding meaningful relief from symptoms is one of the most common, and most challenging, conversations we have with patients in our practice.

Why So Many Standard Options Fall Short

Many of the conventional therapies used for adenomyosis are either contraceptive in nature or carry side effect profiles that make them unsuitable for women hoping to conceive. Combined oral contraceptives and intrauterine systems that release progestin, for example, can help with symptoms, but they also prevent pregnancy. For women who are actively trying to grow their family, these options simply do not align with their goals.

This leaves a real gap. Women in this position often describe feeling caught between two unacceptable choices. Live with the pain and bleeding, or accept a treatment that delays the very thing they are working toward. Neither feels like care. Both can feel like compromise.

Where Progesterone Enters the Conversation

Progesterone is a hormone the body already knows well. It plays an essential role in preparing the uterus for pregnancy, supporting early implantation, and maintaining a healthy gestation. It is also a hormone that women with adenomyosis often process differently. Researchers have observed something called progesterone resistance in adenomyotic tissue, meaning the local response to the body's own progesterone is blunted. The signals that should help calm and stabilize the uterine environment do not land the way they should.

This insight has opened the door to an interesting line of thinking. If the uterine tissue is not responding well to circulating progesterone, perhaps a more targeted approach, one that delivers progesterone directly where it is needed most, could help restore some balance.

Recent preliminary research has examined exactly this idea. A recently published study followed women with symptomatic adenomyosis who were seeking to preserve their fertility. Over a six month period, the women reported meaningful improvements in painful periods, abnormal bleeding, chronic pelvic pain, and discomfort during intimacy. Overall satisfaction with the experience was high. Notably, several pregnancies occurred during the study period, even though pregnancy was not a measured outcome.

The Importance of this Research for Women with Adenomyosis Navigating Infertility

The research is preliminary, and the authors themselves are appropriately cautious in their conclusions. Larger studies with control groups will be needed to confirm what these early findings suggest. Even so, the implications are encouraging.

For women who have been told there is little to offer them, who have weighed the realities of contraceptive based therapies and decided they cannot accept them, the possibility of a low risk and generally well tolerated approach to symptom management is genuinely meaningful. Progesterone has decades of safety data behind it in obstetric practice, particularly in supporting early pregnancy and reducing the risk of preterm birth. That long history of careful use is one of the reasons researchers have been drawn to exploring its role in adenomyosis.

It is also worth saying clearly. This is not a cure. It is not a substitute for individualized medical care. Adenomyosis is a complex condition, and what works well for one person may not be the right path for another. But for women who feel they have been handed a list of options that all require giving up on their fertility goals, the emergence of new research on locally delivered progesterone offers something that has been in short supply. Choice.

A Note on Advocating for Yourself

If you are living with adenomyosis and trying to conceive, please know that your symptoms deserve attention, and your fertility goals deserve respect. The two are not in competition. A thoughtful conversation with your healthcare team, ideally with those familiar with the latest research on adenomyosis, can help you understand what options may be appropriate for your specific situation.

You should never start, stop, or modify any hormonal therapy on your own. The right approach for you depends on a careful evaluation of your medical history, imaging findings, and reproductive plans. What this growing body of research does support, however, is the idea that women with adenomyosis no longer need to feel limited to a binary choice between symptom relief and fertility preservation.

If you are navigating this condition, you are not alone, and you are not without options. We are here to listen, to evaluate, and to help you find a path that honors both your wellbeing and your hopes for the future. Booking a consultation can provide you with the space for a personalized evaluation to review appropriate supportive treatments to help you on your journey.

---

Disclaimer: This blog is for informational purposes only and should not be taken as medical advice. Always consult with your Naturopathic Doctor before starting any new supplement, especially during fertility treatments like IVF.

About Dr. H. Singh, ND

Dr. H. Singh is a Fertility Naturopath based in Ottawa with over ten years of experience focusing exclusively on reproductive health.

He works with individuals and couples across Ontario and Quebec, supporting patients trying to conceive naturally or alongside treatments such as IUI and IVF.

Care focuses on evidence informed strategies to support egg quality, sperm health, hormonal balance, implantation, and early pregnancy.